Predictors of early, intermediate, and late recurrences in randomized phase III trial of adjuvant chemotherapy versus chemoimmunotherapy for locally advanced gastric cancer after curative surgery: Final results of 15-year follow-up

被引：0
|
作者：
Moon, Y. [1 ]
Jeung, H. [1 ]
Rha, S. [1 ]
Yoo, N. [1 ]
Roh, J. [1 ]
Noh, S. [1 ]
Min, J. [1 ]
Kim, B. [1 ]
Chung, H. [1 ]
机构：
[1] Yonsei Univ, Seoul 120749, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.4562
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4562
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Concomitant Cisplatin and Hyperfractionated Radiotherapy in Locally Advanced Head and Neck Cancer: Ten-year Follow-up of a Randomized Phase III Trial (SAKK 10/94)
    Ghadjar, P.
    Simcock, M.
    Studer, G.
    Allal, A. S.
    Ozsahin, M.
    Bernier, J.
    Toepfer, M.
    Zimmermann, F.
    Glanzmann, C.
    Aebersold, D. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S28 - S28
  • [32] Randomized phase III trial of adjuvant sequential chemotherapy plus radiotherapy versus adjuvant radiotherapy alone for locally advanced bladder cancer after radical cystectomy: Urothelial carcinoma subgroup analysis.
    Zaghloul, Mohamed S.
    Christodouleas, John Paul
    Hwang, Wei-Ting
    Smith, Andrew
    Abdalla, Ahmed
    William, Hany
    Baumann, Brian Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [33] CONCOMITANT CISPLATIN AND HYPERFRACTIONATED RADIOTHERAPY IN LOCALLY ADVANCED HEAD-AND-NECK CANCER: 10-YEAR FOLLOW-UP OF A RANDOMIZED PHASE III TRIAL (SAKK 10/94)
    Ghadjar, Pirus
    Simcock, Mathew
    Studer, Gabriela
    Allal, Abdelkarim S.
    Ozsahin, Mahmut
    Bernier, Jacques
    Toepfer, Michael
    Zimmermann, Frank
    Betz, Michael
    Glanzmann, Christoph
    Aebersold, Daniel M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02): : 524 - 531
  • [34] Phase III randomized trial of Thal plus ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-up
    Abdallah, Nadine
    Witzig, Thomas E.
    Kumar, Shaji K.
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Dispenzieri, Angela
    Roy, Vivek
    Gertz, Morie A.
    Bergsagel, P. Leif
    Rajkumar, S. Vincent
    LEUKEMIA, 2024, 38 (05) : 1169 - 1171
  • [35] Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma – updated results after 18-year follow-up
    Nadine Abdallah
    Thomas E. Witzig
    Shaji K. Kumar
    Martha Q. Lacy
    Suzanne R. Hayman
    Angela Dispenzieri
    Vivek Roy
    Morie A. Gertz
    P. Leif Bergsagel
    S. Vincent Rajkumar
    Leukemia, 2024, 38 : 1169 - 1171
  • [36] Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)
    Kreuter, Michael
    Vansteenkiste, Johan
    Fischer, Juergen R.
    Eberhardt, Wilfried E.
    Zabeck, Heike
    Kollmeier, Jens
    Serke, Monika
    Frickhofen, Norbert
    Reck, Martin
    Engel-Riedel, Walburga
    Neumann, Silke
    Thomeer, Michiel
    Schumann, Christian
    De Leyn, Paul
    Graeter, Thomas
    Stamatis, Georgios
    Griesinger, Frank
    Thomas, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (01) : 85 - 93
  • [37] Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial
    Canavese, Giuseppe
    Bruzzi, Paolo
    Catturich, Alessandra
    Tomei, Daniela
    Carli, Franca
    Garrone, Elsa
    Spinaci, Stefano
    Lacopo, Federico
    Tinterri, Corrado
    Dozin, Beatrice
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (08) : 2494 - 2500
  • [38] Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial
    Giuseppe Canavese
    Paolo Bruzzi
    Alessandra Catturich
    Daniela Tomei
    Franca Carli
    Elsa Garrone
    Stefano Spinaci
    Federico Lacopo
    Corrado Tinterri
    Beatrice Dozin
    Annals of Surgical Oncology, 2016, 23 : 2494 - 2500
  • [39] Five-year follow-up results of a randomized phase III trial comparing 4 and 8 courses of S1 adjuvant chemotherapy for pathological stage II gastric cancer: JCOG1104 (OPAS-1).
    Nunobe, Souya
    Yoshikawa, Takaki
    Nishida, Yasunori
    Yamada, Takanobu
    Kaji, Masahide
    Takagane, Akinori
    Teshima, Shin
    Matsushita, Hisayuki
    Tanaka, Ryo
    Hihara, Jun
    Katayama, Hiroshi
    Mizusawa, Junki
    Fukuda, Haruhiko
    Boku, Narikazu
    Terashima, Masanori
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 381 - 381
  • [40] Predictors of Severe Late Toxicity after Hyperfractionated Radiotherapy with or without Concomitant Cisplatin in Locally Advanced Head and Neck Cancer: Results of a Randomized Phase III Trial (SAKK 10/94)
    Ghadjar, P.
    Simcock, M.
    Zimmermann, F.
    Betz, M.
    Bernier, J.
    Studer, G.
    Aebersold, D. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S175 - S175
12345